<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="60779">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02314702</url>
  </required_header>
  <id_info>
    <org_study_id>12-LJH-002L</org_study_id>
    <nct_id>NCT02314702</nct_id>
  </id_info>
  <brief_title>Post Market Clinical Follow-Up Study Protocol for PROFEMUR® L Revision Femoral Stems</brief_title>
  <official_title>Post Market Clinical Follow-Up Study Protocol for PROFEMUR® L Revision Femoral Stems</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>MicroPort Orthopedics Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>MicroPort Orthopedics Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      MicroPort Orthopedics (MPO) is conducting this PMCF study to evaluate the safety and
      efficacy of its THA and resurfacing components marketed in the EU. These types of studies
      are required by regulatory authorities for all THA and resurfacing devices that do not have
      medium to long-term clinical evidence available at the time of gaining approval to market in
      the EU. This study has been designed in accordance with MEDDEV 2.12/2 rev 2.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">October 2027</completion_date>
  <primary_completion_date type="Anticipated">October 2026</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants who require a revision</measure>
    <time_frame>10 years post-operative</time_frame>
    <description>The primary objective of this study is to estimate the revision rate of all components at specified intervals out to 10 years follow-up.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient functional score on the the Oxford Hip Score instrument</measure>
    <time_frame>Screening (First Available), 2-5 years, 5-7 years, and 10 years</time_frame>
    <description>To characterize patient hip-related health status, as assessed by Oxford Hip Scores</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient functional score on the EQ-5D-3L instrument</measure>
    <time_frame>Screening (First Available), 2-5 years, 5-7 years, and 10 years</time_frame>
    <description>To characterize patient general health status, as assessed by EQ-5D-3L scores</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Joint Disease</condition>
  <arm_group>
    <arm_group_label>Revision Total Hip Arthroplasty</arm_group_label>
    <description>Single study group previously implanted with a PROFEMUR® L Revision Femoral Stem</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PROFEMUR® L Revision Femoral Stem</intervention_name>
    <description>Revision Total Hip Arthroplasty</description>
    <arm_group_label>Revision Total Hip Arthroplasty</arm_group_label>
    <other_name>Hip Revision Device</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who have been previously implanted with PROFEMUR® L Revision Femoral Components
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Has undergone revision total hip arthroplasty

          -  Subject is implanted with the specified combination of components

          -  Subject is willing and able to complete required study visits or assessments

        Exclusion Criteria:

          -  Subjects currently enrolled in another clinical study

          -  Subjects unwilling to sign the Informed Consent document

          -  Subjects with substance abuse issues

          -  Subjects who are incarcerated or have pending incarceration
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gavin Bartlett, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Royal Cornwall Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laura Sanchez, MS</last_name>
    <phone>901-290-5279</phone>
    <email>laura.sanchez@ortho.microport.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Leann Speering, MS</last_name>
    <phone>901-290-5924</phone>
    <email>leann.speering@ortho.microport.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Royal Cornwall Hospital</name>
      <address>
        <city>Treliske</city>
        <state>Cornwall</state>
        <zip>TR1 3LJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gavin Bartlett, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <lastchanged_date>December 21, 2016</lastchanged_date>
  <firstreceived_date>December 3, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Osteoarthritis</keyword>
  <keyword>Avascular necrosis</keyword>
  <keyword>Ankylosis</keyword>
  <keyword>Protrusio acetabuli</keyword>
  <keyword>Painful hip dysplasia</keyword>
  <keyword>Rheumatoid arthritis</keyword>
  <keyword>Correction of functional deformity</keyword>
  <keyword>Revision procedures</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Joint Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
